Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncotelic Therapeutics Inc OTLC

Healthcare Biotechnology
Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing drugs for the treatment of orphan oncology indications, developing antisense and small molecule injectable drugs for the treatment of cancer. The Company has eight primary drug and AI technology programs: AL-101, an intranasal drug and delivery system for intra-nasal Apomorphine for the treatment of... see more

OTCQB:OTLC - Post Discussion

Oncotelic Therapeutics Inc > Oncotelic Announces that ORF8 Mutations are Driving the...
View:
Post by DepartedSe7en on Dec 22, 2021 11:18am

Oncotelic Announces that ORF8 Mutations are Driving the...

Oncotelic Announces that ORF8 Mutations are Driving the Evolution of the Delta and the Omicron Variants: https://www.globenewswire.com/news-release/2021/12/22/2356662/0/en/ONCOTELIC-ANNOUNCES-THAT-ORF8-MUTATIONS-ARE-DRIVING-THE-EVOLUTION-OF-THE-DELTA-AND-THE-OMICRON-VARIANTS.html
Be the first to comment on this post
Oncotelic Therapeutics Inc